Lin Zhou
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 13
- Surgery 49
- Organ Transplantation Techniques and Outcomes 36
- Co-authors
- Shusen Zheng (196 shared papers)Haiyang Xie (161 shared papers)Jian Wu (28 shared papers)Xiao Xu (41 shared papers)Shengyong Yin (35 shared papers)Jiacheng Huang (6 shared papers)Yiting Qiao (7 shared papers)Shengzhang Lin (3 shared papers)
- Journals
- PLoS ONE (10 papers)Cancer Letters (7 papers)International Journal of Biological Sciences (6 papers)Oncotarget (6 papers)Journal of Translational Medicine (6 papers)
- Partner nations
- ChinaMadagascarUnited States
In The Last Decade
Lin Zhou
291 papers receiving 9.5k citations
Lin Zhou's Hit Papers
Peers
Comparison fields: 5 of 153
- Hepatology 1.0k
- Cancer Research 1.6k
- Oncology 1.7k
- Transplantation 167
- Molecular Biology 4.2k
Countries citing papers authored by Lin Zhou
This map shows the geographic impact of Lin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Zhou more than expected).
Fields of papers citing papers by Lin Zhou
This network shows the impact of papers produced by Lin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Zhou. The network helps show where Lin Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 301 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Extracellular matrix and its therapeutic potential for cancer treatment Hit paper breakdown → | 2021 | 636 |
| 2 | Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma Hit paper breakdown → | 2018 | 576 |
| 3 | WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1 Hit paper breakdown → | 2019 | 489 |
| 4 | 2019 | 233 | |
| 5 | 2020 | 208 | |
| 6 | 2015 | 203 | |
| 7 | 2017 | 179 | |
| 8 | 2017 | 173 | |
| 9 | 2011 | 139 | |
| 10 | 2020 | 138 | |
| 11 | 2017 | 136 | |
| 12 | 2015 | 130 | |
| 13 | 2022 | 117 | |
| 14 | 2007 | 114 | |
| 15 | 2011 | 111 | |
| 16 | 2009 | 107 | |
| 17 | 2014 | 103 | |
| 18 | 2019 | 96 | |
| 19 | 2013 | 90 | |
| 20 | 2014 | 90 |
About Lin Zhou
Lin Zhou is a scholar working on Molecular Biology, Surgery, Oncology, Epidemiology and Hepatology, having authored 301 papers that have together received 9.6k indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (36 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Liver Disease and Transplantation (19 papers), Cancer Mechanisms and Therapy (14 papers), Liver Disease Diagnosis and Treatment (13 papers), RNA modifications and cancer (13 papers), Hepatitis B Virus Studies (12 papers) and Immunotherapy and Immune Responses (12 papers). The work is most often cited by research in Hepatology (1.0k citations), Cancer Research (1.6k citations), Oncology (1.7k citations), Transplantation (167 citations) and Molecular Biology (4.2k citations). Lin Zhou has collaborated with scholars based in China, Madagascar and United States. Frequent co-authors include Shusen Zheng, Haiyang Xie, Jian Wu, Xiao Xu, Shengyong Yin, Jiacheng Huang, Yiting Qiao, Shengzhang Lin, Dalong Wan and Lele Zhang. Their work appears in journals such as PLoS ONE, Cancer Letters, International Journal of Biological Sciences, Oncotarget and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.